Revelation Biosciences Warrant
REVBW
17 hedge funds and large institutions have $6.11M invested in Revelation Biosciences Warrant in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
65% more capital invested
Capital invested by funds: $3.71M → $6.11M (+$2.4M)
13% more funds holding
Funds holding: 15 → 17 (+2)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$21.9K |
| 2 |
PCM
Prelude Capital Management
New York
|
+$10.2K |
| 3 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$9.1K |
| 4 |
Walleye Trading
New York
|
+$7.88K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$90.9K |
| 2 |
ES
Equitec Specialists
Chicago,
Illinois
|
-$9K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$1.88K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.54K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$180 |
REVBW Hedge Fund Activity: Q2 2021 in Review
17 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q2 2021, worth a combined $6.11M — up 65% from $3.71M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new REVBW positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Walleye Capital, adding an estimated $21.9K. The largest seller was Polar Asset Management Partners, cutting an estimated $90.9K.
- 17 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q2 2021, up from 15 in Q1 2021.
- Funds reported $6.11M of Revelation Biosciences Warrant stock for Q2 2021, up 65% quarter-over-quarter.
- 3 funds opened new Revelation Biosciences Warrant positions in Q2 2021 and 1 closed out, a net change of +2 holders.
- The largest Revelation Biosciences Warrant buyer in Q2 2021 was Walleye Capital, an estimated $21.9K added.
- The largest Revelation Biosciences Warrant seller in Q2 2021 was Polar Asset Management Partners, an estimated $90.9K sold.
Based on aggregated 13F filings for Q2 2021.